Literature DB >> 21294756

The μ opioid receptor is not involved in ethanol-stimulated dopamine release in the ventral striatum of C57BL/6J mice.

Vorani Ramachandra1, Francis Kang, Christine Kim, Alan S Nova, Ankur Bajaj, F Scott Hall, George R Uhl, Rueben A Gonzales.   

Abstract

BACKGROUND: The mu opioid receptor (MOR) has previously been found to regulate ethanol-stimulated dopamine release under some, but not all, conditions. A difference in ethanol-evoked dopamine release between male and female mixed background C57BL/6J-129SvEv mice led to questions about its ubiquitous role in these effects of ethanol. Using congenic C57BL/6J MOR knockout (KO) mice and C57BL/6J mice pretreated with an irreversible MOR antagonist, we investigated the function of this receptor in ethanol-stimulated dopamine release.
METHODS: Microdialysis was used to monitor dopamine release and ethanol clearance in MOR -/-, +/+, and +/- . male and female mice after intraperitoneal (i.p.) injections of 1.0, 2.0, and 3.0 g/kg ethanol (or saline). We also measured the increase in dopamine release after 5 mg/kg morphine (i.p.) in male and female MOR+/+ and -/- mice. In a separate experiment, male C57BL/6J mice were pretreated with either the irreversible MOR antagonist beta funaltrexamine (BFNA) or vehicle, and dopamine levels were monitored after administration of 2 g/kg ethanol or 5 mg/kg morphine.
RESULTS: Although ethanol-stimulated dopamine release at all the 3 doses of alcohol tested, there were no differences between MOR+/+, -/-, and +/- mice in these effects. Female mice had a more prolonged effect compared to males at the 1 g/kg dose. Administration of 2 g/kg ethanol also caused a similar increase in dopamine levels in both saline-pretreated and BFNA-pretreated mice. Five mg/kg morphine caused a significant increase in dopamine levels in MOR+/+ mice but not in MOR-/- mice and in saline-pretreated mice but not in BFNA-pretreated mice. Intraperitoneal saline injections had a significant, albeit small and transient, effect on dopamine release when given in a volume equivalent to the ethanol doses, but not in a volume equivalent to the 5 mg/kg morphine dose. Ethanol pharmacokinetics were similar in all genotypes and both sexes at each dose and in both pretreatment groups.
CONCLUSIONS: MOR is not involved in ethanol-stimulated dopamine release in the ventral striatum of C57BL/6J mice.
Copyright © 2011 by the Research Society on Alcoholism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21294756      PMCID: PMC3655702          DOI: 10.1111/j.1530-0277.2010.01423.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  46 in total

1.  Opioids in the hypothalamus control dopamine and acetylcholine levels in the nucleus accumbens.

Authors:  Pedro Rada; Jessica R Barson; Sarah F Leibowitz; Bartley G Hoebel
Journal:  Brain Res       Date:  2009-11-27       Impact factor: 3.252

2.  Mu opioid receptor modulation of somatodendritic dopamine overflow: GABAergic and glutamatergic mechanisms.

Authors:  V I Chefer; L Denoroy; A Zapata; T S Shippenberg
Journal:  Eur J Neurosci       Date:  2009-07-15       Impact factor: 3.386

3.  Single-nucleotide polymorphism (A118G) in exon 1 of OPRM1 gene causes alteration in downstream signaling by mu-opioid receptor and may contribute to the genetic risk for addiction.

Authors:  Ishani Deb; Japashish Chakraborty; Prasanta Kumar Gangopadhyay; Susanta Roy Choudhury; Sumantra Das
Journal:  J Neurochem       Date:  2009-11-04       Impact factor: 5.372

4.  Effect of KEPI (Ppp1r14c) deletion on morphine analgesia and tolerance in mice of different genetic backgrounds: when a knockout is near a relevant quantitative trait locus.

Authors:  J Drgonova; D B Zimonjic; F S Hall; G R Uhl
Journal:  Neuroscience       Date:  2009-10-09       Impact factor: 3.590

5.  Ethanol preference is inversely correlated with ethanol-induced dopamine release in 2 substrains of C57BL/6 mice.

Authors:  Vorani Ramachandra; Steven Phuc; Ana Crystal Franco; Rueben A Gonzales
Journal:  Alcohol Clin Exp Res       Date:  2007-07-25       Impact factor: 3.455

6.  The shell of the nucleus accumbens has a higher dopamine response compared with the core after non-contingent intravenous ethanol administration.

Authors:  E C Howard; C J Schier; J S Wetzel; C L Duvauchelle; R A Gonzales
Journal:  Neuroscience       Date:  2008-04-16       Impact factor: 3.590

Review 7.  Addiction genetics and pleiotropic effects of common haplotypes that make polygenic contributions to vulnerability to substance dependence.

Authors:  George R Uhl; Tomas Drgon; Catherine Johnson; Qing-Rong Liu
Journal:  J Neurogenet       Date:  2009-01-19       Impact factor: 1.250

8.  The dopamine response in the nucleus accumbens core-shell border differs from that in the core and shell during operant ethanol self-administration.

Authors:  Elaina C Howard; Christina J Schier; Jeremy S Wetzel; Rueben A Gonzales
Journal:  Alcohol Clin Exp Res       Date:  2009-04-30       Impact factor: 3.455

9.  A method for mapping intralocus interactions influencing excessive alcohol drinking.

Authors:  Tamara J Phillips; Cheryl Reed; Sue Burkhart-Kasch; Na Li; Robert Hitzemann; Chia-Hua Yu; Lauren L Brown; Melinda L Helms; John C Crabbe; John K Belknap
Journal:  Mamm Genome       Date:  2009-12-22       Impact factor: 2.957

10.  Hybrid mice as genetic models of high alcohol consumption.

Authors:  Y A Blednov; A R Ozburn; D Walker; S Ahmed; J K Belknap; R A Harris
Journal:  Behav Genet       Date:  2009-10-02       Impact factor: 2.965

View more
  4 in total

1.  Sex differences in the effects of adolescent social deprivation on alcohol consumption in μ-opioid receptor knockout mice.

Authors:  Yuki Moriya; Yoshiyuki Kasahara; F Scott Hall; Yasufumi Sakakibara; George R Uhl; Hiroaki Tomita; Ichiro Sora
Journal:  Psychopharmacology (Berl)       Date:  2014-11-04       Impact factor: 4.530

2.  The opioid antagonist, β-funaltrexamine, inhibits NF-κB signaling and chemokine expression in human astrocytes and in mice.

Authors:  Randall L Davis; Subhas Das; J Thomas Curtis; Craig W Stevens
Journal:  Eur J Pharmacol       Date:  2015-05-22       Impact factor: 4.432

3.  Effects of naltrexone on neural and subjective response to alcohol in treatment-seeking alcohol-dependent patients.

Authors:  Primavera A Spagnolo; Vijay A Ramchandani; Melanie L Schwandt; Lishu Zhang; Sara K Blaine; Julie M Usala; Kristie A Diamond; Monte J Phillips; David T George; Reza Momenan; Markus Heilig
Journal:  Alcohol Clin Exp Res       Date:  2014-12       Impact factor: 3.455

Review 4.  FACTORS CONTRIBUTING TO THE ESCALATION OF ALCOHOL CONSUMPTION.

Authors:  Michael T Bowen; Olivier George; Dawn E Muskiewicz; F Scott Hall
Journal:  Neurosci Biobehav Rev       Date:  2021-11-25       Impact factor: 8.989

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.